CBD was found to increase TIMP-1 and ICAM-1 expression in a dose-dependent manner in lung cancer cell lines and inhibited the spread and invasion of human lung cancer xenografts in mice, partially due to the increase in ICAM-1 and TIMP-1. This evidence concerns the gene ICAM1 and lung carcinoma.